Farmers National Bank Grows Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Farmers National Bank boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 15.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,351 shares of the healthcare conglomerate’s stock after acquiring an additional 851 shares during the period. Farmers National Bank’s holdings in UnitedHealth Group were worth $3,234,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of UNH. Edge Capital Group LLC grew its stake in UnitedHealth Group by 1.0% during the 4th quarter. Edge Capital Group LLC now owns 2,906 shares of the healthcare conglomerate’s stock valued at $1,530,000 after acquiring an additional 29 shares in the last quarter. Capital Research Global Investors boosted its holdings in UnitedHealth Group by 2.2% in the 4th quarter. Capital Research Global Investors now owns 15,122,203 shares of the healthcare conglomerate’s stock valued at $7,961,369,000 after purchasing an additional 324,733 shares during the last quarter. Amussen Hunsaker Associates LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at about $203,000. Tower Research Capital LLC TRC boosted its holdings in UnitedHealth Group by 365.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 142,228 shares of the healthcare conglomerate’s stock valued at $74,879,000 after purchasing an additional 111,659 shares during the last quarter. Finally, Alapocas Investment Partners Inc. boosted its holdings in UnitedHealth Group by 0.7% in the 4th quarter. Alapocas Investment Partners Inc. now owns 14,982 shares of the healthcare conglomerate’s stock valued at $7,888,000 after purchasing an additional 99 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

Analyst Upgrades and Downgrades

UNH has been the topic of several recent analyst reports. Robert W. Baird upped their price objective on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, September 25th. Morgan Stanley upped their price objective on shares of UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Truist Financial upped their price objective on shares of UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Finally, TD Cowen upped their price objective on shares of UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Two equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $614.17.

UnitedHealth Group Trading Down 0.2 %

Shares of NYSE:UNH opened at $583.33 on Wednesday. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $607.94. The company’s 50 day moving average is $580.50 and its two-hundred day moving average is $525.71. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. The company has a market cap of $538.66 billion, a PE ratio of 35.66, a P/E/G ratio of 1.62 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. The company had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $6.14 EPS. Equities analysts predict that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.44%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is 51.34%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.